Page last updated: 2024-08-23

acetylgalactosamine and deferiprone

acetylgalactosamine has been researched along with deferiprone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Crouch, PJ; Dames, S; Eisermann, M; Grigoriadis, G; Kysenius, K; Ng, GZ; Nualkaew, T; Schaeper, U; Vadolas, J; Vilcassim, S	1

Other Studies

1 other study(ies) available for acetylgalactosamine and deferiprone

Article	Year
SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia. British journal of haematology, 2021, Volume: 194, Issue:1 Topics: Acetylgalactosamine; Animals; beta-Thalassemia; Deferiprone; Disease Models, Animal; Drug Therapy, Combination; Erythropoiesis; Female; Gene Expression Profiling; Hepcidins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Magnesium; Membrane Proteins; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Spleen; Zinc	2021

Article

Year

SLN124, a GalNac-siRNA targeting transmembrane serine protease 6, in combination with deferiprone therapy reduces ineffective erythropoiesis and hepatic iron-overload in a mouse model of β-thalassaemia.

British journal of haematology, 2021, Volume: 194, Issue:1

Topics: Acetylgalactosamine; Animals; beta-Thalassemia; Deferiprone; Disease Models, Animal; Drug Therapy, Combination; Erythropoiesis; Female; Gene Expression Profiling; Hepcidins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Magnesium; Membrane Proteins; Mice; Mice, Inbred C57BL; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; Serine Endopeptidases; Spleen; Zinc

2021